Short-Term Outcomes for Veterans Receiving Basal Insulin, Metformin, and a Sulfonylurea Who Are Started on a Third Noninsulin Agent Versus Prandial Insulin

AIMS. Despite numerous recent advances in the management of patients with type 2 diabetes, there remains a paucity of data to guide sequential treatment intensification. METHODS. This was a single-center, retrospective cohort study of patients receiving metformin, basal insulin, and a sulfonylurea w...

Descripción completa

Detalles Bibliográficos
Autores principales: Santeusanio, Andrew D., Bowen, Monica M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2018
Materias:
Feature Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092894/
https://www.ncbi.nlm.nih.gov/pubmed/30140142
http://dx.doi.org/10.2337/ds17-0068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6092894/
https://www.ncbi.nlm.nih.gov/pubmed/30140142
http://dx.doi.org/10.2337/ds17-0068

Ejemplares similares